Review
Accepted on 29 Dec 2025
From Ketogenic Metabolism to Targeted Therapeutics: Current Advances in β-Hydroxybutyrylation
in Cancer Immunity and Immunotherapy
Review
Accepted on 29 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 29 Dec 2025
in Cancer Immunity and Immunotherapy
Review
Accepted on 29 Dec 2025
in Cancer Immunity and Immunotherapy
Review
Accepted on 29 Dec 2025
in Cancer Immunity and Immunotherapy
Case Report
Accepted on 29 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 29 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 26 Dec 2025
in Cancer Immunity and Immunotherapy
Review
Accepted on 26 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 26 Dec 2025
in Cancer Immunity and Immunotherapy
Review
Accepted on 25 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 25 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 25 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 25 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 25 Dec 2025
in Cancer Immunity and Immunotherapy
Review
Accepted on 25 Dec 2025
in Cancer Immunity and Immunotherapy
Review
Accepted on 25 Dec 2025
in Cancer Immunity and Immunotherapy
Mini Review
Accepted on 25 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 24 Dec 2025
in Cancer Immunity and Immunotherapy
Review
Accepted on 24 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 24 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 24 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 23 Dec 2025
in Cancer Immunity and Immunotherapy
Correction
Accepted on 23 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 23 Dec 2025
in Cancer Immunity and Immunotherapy